Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
3,023
Frequently Asked Questions
What is Market Cap of Haemonetics Corp.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Haemonetics Corp. market cap is $2.32B.
What is the 52-week high for Haemonetics Corp.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Haemonetics Corp. 52 week high is $94.99 as of September 28, 2025.
What is the 52-week low for Haemonetics Corp.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Haemonetics Corp. 52 week low is $47.32 as of September 28, 2025.
What is Haemonetics Corp. stock price today?
Haemonetics Corp. stock price today is $48.17.
What was Haemonetics Corp. stock price yesterday?
Haemonetics Corp. stock price yesterday was $47.67.
What is the PE ratio of Haemonetics Corp.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Haemonetics Corp.’s P/E ratio is 14.70.
What is the Price-to-Book ratio of Haemonetics Corp.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Haemonetics Corp. P/B ratio is 2.6293.
What is the 50-day moving average of Haemonetics Corp.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Haemonetics Corp. 50-day moving average is $59.08.
